Copmed Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 9.60 M
as on 16-11-2024
- Company Age 36 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 54.85 Cr
as on 16-11-2024
- Satisfied Charges ₹ 25.30 Cr
as on 16-11-2024
- Revenue -10.51%
(FY 2023)
- Profit -0.14%
(FY 2023)
- Ebitda -7.41%
(FY 2023)
- Net Worth 16.93%
(FY 2023)
- Total Assets 10.42%
(FY 2023)
About Copmed Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 9.60 M.
The company currently has active open charges totaling ₹54.85 Cr. The company has closed loans amounting to ₹25.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Abhay Srivastava, Anju Jha, Akhlas Ahmed, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74899DL1988PTC033151
- Company No.
033151
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Copmed Pharmaceuticals Private Limited offer?
Copmed Pharmaceuticals Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Antidiabetic Medicine, Nutraceuticals & Dietary Supplements, Dietary Supplements, Antianginal Drugs, Diabetes Medicine, Anti Infective Drugs & Medicines, Antibacterial Drugs, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant.
Who are the key members and board of directors at Copmed Pharmaceuticals?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhay Srivastava  | Director | 01-Mar-2021 | Current |
| Anju Jha | Director | 26-Mar-2021 | Current |
| Akhlas Ahmed | Director | 01-Mar-2021 | Current |
| Jagmohan Sharma | Whole-Time Director | 04-Sep-2024 | Current |
| Bhupendra Kaushik | Director | 26-Mar-2021 | Current |
| Veer Pal | Director | 31-Jul-2009 | Current |
Financial Performance and Corporate Structure Insights of Copmed Pharmaceuticals.
Copmed Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.51% decrease. The company also saw a slight decrease in profitability, with a 0.14% decrease in profit. The company's net worth Soared by an impressive increase of 16.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Copmed Pharmaceuticals?
In 2023, Copmed Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sirmour Remedies Private LimitedActive 35 years 2 monthsAbhay Srivastava and Akhlas Ahmed are mutual person
Packtime Innovations Private LimitedActive 9 years 6 monthsAnju Jha and Akhlas Ahmed are mutual person
Relax Pharmaceuticals Private LimitedActive 27 years 4 monthsAbhay Srivastava, Anju Jha and 3 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Sep 2021 | ₹3.98 M | Open |
Others Creation Date: 22 Sep 2021 | ₹4.53 M | Open |
Hdfc Bank Limited Creation Date: 30 Sep 2010 | ₹54.00 Cr | Open |
How Many Employees Work at Copmed Pharmaceuticals?
Copmed Pharmaceuticals has a workforce of 349 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Copmed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Copmed Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
